|
Oct 9
|
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
|
|
Oct 7
|
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
|
|
Jul 30
|
Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
|
|
Jul 29
|
5 Biotech Stocks to Bet On Bright Industry Prospects
|
|
Jul 29
|
Exploring Analyst Estimates for Moderna (MRNA) Q2 Earnings, Beyond Revenue and EPS
|
|
Jul 29
|
RSV vaccine makers vying for market share in second year of shots
|
|
Jul 26
|
Moderna (MRNA) Stock Before Q2 Earnings: To Buy or Not to Buy?
|
|
Jul 26
|
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
|
|
Jul 26
|
Moderna Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution
|
|
Jul 26
|
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
|
|
Jul 24
|
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
|
Jul 23
|
Why Moderna (MRNA) Dipped More Than Broader Market Today
|
|
Jun 25
|
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
|
|
Jun 25
|
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
|
|
Jun 25
|
Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
|
|
Jun 24
|
The FDA awarded a record number of review designations to mRNA vaccines in 2023
|
|
Jun 22
|
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
|
|
Jun 18
|
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
|
|
Jun 6
|
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
|
|
Jun 6
|
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program
|